Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

State of the States

A roundup of regulatory activity around the country
Summer 2022

Sickness and Society: The Future of Infectious Disease in the Workplace

Strategies for a safer, healthier workface amid COVID-19 and beyond.
Winter 2021/2022

State of the States

Sandy Shtab, Healthesystems AVP of Advocacy and Compliance, comments on regulatory activity across the country.
Winter 2021/2022

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

FDA Approves Novel Non-Opioid Journavx for Moderate to Severe Pain

A first-in-class medication, Journavx targets pain-signaling pathways involving sodium channels.
Feb 2025

2025 Workers’ Comp Industry Insights Survey Report

The seventh annual survey report highlights the top challenges and priorities for 515 industry stakeholders.
Feb 2025

Flurry of States Eye Updates for Cancer and PTSD Presumptions

Various states are proposing modifications to existing presumptions to expand coverage for first responders.
Feb 2025

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

NSAID Use and COVID-19

FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.
Mar 2020

COVID-19 and Clinical Trials

COVID-19 drug trials are underway, but the pandemic is disrupting clinical testing.
Mar 2020

JAMA Compares Effectiveness of Treatment Pathways for Opioid Use Disorder

A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.
Mar 2020
1 … 17 18 19 20 21 … 28

Whitepapers

lockmap-markermagnifiercrossmenucross-circle